2-(4-acetyl-4-phenylpiperidin-1-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;bis(6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide);6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide

C181H218N24O15S3 — CID 158308781

About 2-(4-acetyl-4-phenylpiperidin-1-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;bis(6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide);6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide

2-(4-acetyl-4-phenylpiperidin-1-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;bis(6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide);6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide (PubChem CID 158308781) has the molecular formula C181H218N24O15S3 and a molecular weight of 3066.09 g/mol. Its IUPAC name is 2-(4-acetyl-4-phenylpiperidin-1-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;bis(6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide);6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide.

Molecular Properties

• Compound Name: 2-(4-acetyl-4-phenylpiperidin-1-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;bis(6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide);6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide
• PubChem CID: 158308781
• Molecular Formula: C181H218N24O15S3
• Molecular Weight: 3066.09 g/mol
• Exact Mass: 3063.62
• IUPAC Name: 2-(4-acetyl-4-phenylpiperidin-1-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;bis(6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide);6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide
• SMILES: CC(=O)C1(c2ccccc2)CCN(CC(=O)NC2CCc3ccccc3C2Cc2cccnc2)CC1.CN(C)C(CCCCNS(=O)(=O)c1ccccc1)C(=O)NC1CCc2ccccc2[C@@H]1Cc1cccnc1.CN(C)C(CCCCNS(=O)(=O)c1ccccc1)C(=O)NC1CCc2ccccc2[C@H]1Cc1cccnc1.CN(C)C(CCCCNS(=O)(=O)c1ccccc1)C(=O)NC1CCc2ccccc2[C@H]1Cc1cccnc1.COc1ccccc1N1CCN(CC(=O)NC2CCc3ccccc3C2Cc2cccnc2)CC1.O=C(CN1CCC2(CC1)C(=O)NCN2c1ccccc1)NC1CCc2ccccc2C1Cc1cccnc1
• InChI: InChI=1S/C31H35N5O2.C31H35N3O2.3C30H38N4O3S.C29H34N4O2/c37-29(21-35-17-14-31(15-18-35)30(38)33-22-36(31)25-9-2-1-3-10-25)34-28-13-12-24-8-4-5-11-26(24)27(28)19-23-7-6-16-32-20-23;1-23(35)31(26-10-3-2-4-11-26)15-18-34(19-16-31)22-30(36)33-29-14-13-25-9-5-6-12-27(25)28(29)20-24-8-7-17-32-21-24;3*1-34(2)29(16-8-9-20-32-38(36,37)25-13-4-3-5-14-25)30(35)33-28-18-17-24-12-6-7-15-26(24)27(28)21-23-11-10-19-31-22-23;1-35-28-11-5-4-10-27(28)33-17-15-32(16-18-33)21-29(34)31-26-13-12-23-8-2-3-9-24(23)25(26)19-22-7-6-14-30-20-22/h1-11,16,20,27-28H,12-15,17-19,21-22H2,(H,33,38)(H,34,37);2-12,17,21,28-29H,13-16,18-20,22H2,1H3,(H,33,36);3*3-7,10-15,19,22,27-29,32H,8-9,16-18,20-21H2,1-2H3,(H,33,35);2-11,14,20,25-26H,12-13,15-19,21H2,1H3,(H,31,34)/t;;3*27-,28?,29?;/m..110./s1
• InChIKey: GNKOXIKLUVKUPL-ZPFBQTJXSA-N
• XLogP: 23.15
• TPSA: 471.77 Ų
• H-Bond Donors: 10
• H-Bond Acceptors: 29
• Rotatable Bonds: 56
• Heavy Atoms: 223
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3066.09
LogP ≤ 5	23.15
H-Bond Donors ≤ 5	10
H-Bond Acceptors ≤ 10	29

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-(4-acetyl-4-phenylpiperidin-1-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;bis(6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide);6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide?

The IUPAC name of 2-(4-acetyl-4-phenylpiperidin-1-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;bis(6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide);6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide (CID 158308781) is 2-(4-acetyl-4-phenylpiperidin-1-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;bis(6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide);6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide.

What is the SMILES notation for 2-(4-acetyl-4-phenylpiperidin-1-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;bis(6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide);6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide?

The canonical SMILES for 2-(4-acetyl-4-phenylpiperidin-1-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;bis(6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide);6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide is CC(=O)C1(c2ccccc2)CCN(CC(=O)NC2CCc3ccccc3C2Cc2cccnc2)CC1.CN(C)C(CCCCNS(=O)(=O)c1ccccc1)C(=O)NC1CCc2ccccc2[C@@H]1Cc1cccnc1.CN(C)C(CCCCNS(=O)(=O)c1ccccc1)C(=O)NC1CCc2ccccc2[C@H]1Cc1cccnc1.CN(C)C(CCCCNS(=O)(=O)c1ccccc1)C(=O)NC1CCc2ccccc2[C@H]1Cc1cccnc1.COc1ccccc1N1CCN(CC(=O)NC2CCc3ccccc3C2Cc2cccnc2)CC1.O=C(CN1CCC2(CC1)C(=O)NCN2c1ccccc1)NC1CCc2ccccc2C1Cc1cccnc1.

What is the InChIKey of 2-(4-acetyl-4-phenylpiperidin-1-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;bis(6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide);6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide?

The InChIKey is GNKOXIKLUVKUPL-ZPFBQTJXSA-N. The full InChI is InChI=1S/C31H35N5O2.C31H35N3O2.3C30H38N4O3S.C29H34N4O2/c37-29(21-35-17-14-31(15-18-35)30(38)33-22-36(31)25-9-2-1-3-10-25)34-28-13-12-24-8-4-5-11-26(24)27(28)19-23-7-6-16-32-20-23;1-23(35)31(26-10-3-2-4-11-26)15-18-34(19-16-31)22-30(36)33-29-14-13-25-9-5-6-12-27(25)28(29)20-24-8-7-17-32-21-24;3*1-34(2)29(16-8-9-20-32-38(36,37)25-13-4-3-5-14-25)30(35)33-28-18-17-24-12-6-7-15-26(24)27(28)21-23-11-10-19-31-22-23;1-35-28-11-5-4-10-27(28)33-17-15-32(16-18-33)21-29(34)31-26-13-12-23-8-2-3-9-24(23)25(26)19-22-7-6-14-30-20-22/h1-11,16,20,27-28H,12-15,17-19,21-22H2,(H,33,38)(H,34,37);2-12,17,21,28-29H,13-16,18-20,22H2,1H3,(H,33,36);3*3-7,10-15,19,22,27-29,32H,8-9,16-18,20-21H2,1-2H3,(H,33,35);2-11,14,20,25-26H,12-13,15-19,21H2,1H3,(H,31,34)/t;;3*27-,28?,29?;/m..110./s1.

What are the key properties of 2-(4-acetyl-4-phenylpiperidin-1-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;bis(6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide);6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide?

2-(4-acetyl-4-phenylpiperidin-1-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;bis(6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide);6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide has a molecular weight of 3066.09 g/mol, XLogP of 23.15, 56 rotatable bonds, 10 hydrogen bond donors, and 29 hydrogen bond acceptors.

Where does this data come from?

All data for 2-(4-acetyl-4-phenylpiperidin-1-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;bis(6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1R)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide);6-(benzenesulfonamido)-2-(dimethylamino)-N-[(1S)-1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]hexanamide;2-[4-(2-methoxyphenyl)piperazin-1-yl]-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide;2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-N-[1-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydronaphthalen-2-yl]acetamide is sourced from PubChem (CID 158308781), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).